Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2014

Open Access 01-12-2014 | Study protocol

Evaluation of a tailored intervention to improve management of overweight and obesity in primary care: study protocol of a cluster randomised controlled trial

Authors: Jane Krause, Shona Agarwal, Danielle H Bodicoat, Arne Ring, David Shepherd, Stephen Rogers, Michel Wensing, Richard Baker

Published in: Trials | Issue 1/2014

Login to get access

Abstract

Background

In the UK around 22% of men and 24% of women are obese, and there are varying but worrying levels in other European countries. Obesity is a chronic condition that carries an important health risk. National guidelines, for use in England, on the management of people who are overweight or obese have been published by the National Institute for Health and Clinical Excellence (NICE, 2006). NICE recommendations for primary care teams are: determine the degree of overweight and obesity; assess lifestyle, comorbidities and willingness to change; offer multicomponent management of overweight and obesity; referral to external services when appropriate. This study investigates a tailored intervention to improve the implementation of these recommendations by primary care teams.

Methods/Design

The study is a cluster randomised controlled trial. Primary care teams will be recruited from the East Midlands of England, and randomised into two study arms: 1) the study group, in which primary care teams are offered a set of tailored interventions to help implement the NICE guidelines for overweight and obesity; or 2) the control group in which primary care teams continue to practice usual care. The primary outcome is the proportion of overweight or obese patients for whom the primary care team adheres to the NICE guidelines. Secondary outcomes include the proportion of patients with a record of lifestyle assessment, referral to external weight loss services, the proportion of obese patients who lose weight during the intervention period, and the mean weight change over the same period.

Discussion

Although often recommended, the methods of tailoring implementation interventions to account for the determinants of practice are not well developed. This study is part of a programme of studies seeking to develop the methods of tailored implementation.

Trial registration

Current Controlled Trials ISRCTN07457585. Registered 09/08/2013. Randomisation commenced 30/08/2013.
Appendix
Available only for authorised users
Literature
1.
NICE: Obesity: Guidance on the Prevention, Identification, Assessment and Management of Overweight and Obesity in Adults and Children. 2006, London: National Institute for Health and Clinical Excellence
2.
3.
Review M: Fair Society, Healthy Lives. 2010, London: The Marmot Review
4.
Wang YC, McPherson K, Marsh T, Gortmaker SL, Brown M: Health and economic burden of the projected obesity trends in the USA and the UK. Lancet. 2011, 378: 815-825. 10.1016/S0140-6736(11)60814-3.CrossRefPubMed
5.
Gaziano JM: Fifth phase of the epidemiologic transition: the age of obesity and inactivity. JAMA. 2010, 303: 275-276. 10.1001/jama.2009.2025.CrossRefPubMed
6.
Sturm R: The effects of obesity, smoking, and drinking on medical problems and cost. Health Aff. 2002, 21 (Suppl 2): 245-253.CrossRef
7.
Finkelstein EA, Trogdon JG, Cohen JW, Dietz W: Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff. 2009, 28 (Suppl 5): 822-831.CrossRef
8.
Larsson U, Karlsson J, Sullivan M: Impact of overweight and obesity on health-related quality of life - a Swedish population study. Int J Obes. 2002, 26: 417-424. 10.1038/sj.ijo.0801919.CrossRef
9.
Department of Health: Healthy Lives, Health People. A Call to Action on Obesity in England. 2011, London: Department of Health
10.
Department of Health: Improving Outcomes and Supporting Transparency. Part 1A: A Public Health Outcomes Framework for England 2012–2016. 2012, London: Department of Health
11.
12.
13.
Maryon-Davis A: Weight management in primary care: how can it be made more effective?. Proceed Nutr Soc. 2005, 64: 97-103. 10.1079/PNS2004414.CrossRef
14.
Gunther S, Guo F, Sinfield P, Rogers S, Baker R: Barriers and enablers to managing obesity in general practice: a practical approach for use in implementation activities. Qual Primary Care. 2012, 20: 93-103.
15.
Flodgren G, Deane K, Dickinson HO, Kirk S, Alberti H, Beyer FR, Brown JG, Penney TL, Summerbell CD, Eccles MP: Interventions to change the behaviour of health professionals and the organisation of care to promote weight reduction in overweight and obese adults. Cochrane Database Syst Rev. 2010, 3: CD000984
16.
Wensing M, Oxman A, Baker R, Godycki-Cwirko M, Flottorp S, Szecsenyi J, Grimshaw J, Eccles M: Tailored Implementation for Chronic Diseases (TICD): a project protocol. Implement Sci. 2011, 6: 103-10.1186/1748-5908-6-103.CrossRefPubMedPubMedCentral
17.
18.
Employers NHS: 2013/14 General Medical Services (GMS) Contract and Quality and Outcomes Framework (QOF). Guidance for GMS Contract. 2013, London: NHS Employers, General Practitioners Committee, NHS England
19.
20.
21.
Baker R, Camosso-Stefinovic J, Gillies C, Shaw EJ, Cheater F, Flottorp S, Robertson N: Tailored interventions to overcome identified barriers to change: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2010, 3: CD005470
22.
Flottorp SA, Oxman AD, Krause J, Musila NR, Wensing M, Godycki-Cwirko M, Baker R, Eccles MP: A checklist for identifying determinants of practice: a systematic review and synthesis of frameworks and taxonomies of factors that prevent or enable improvements in health care professional practice. Implement Sci. 2013, 8: 1-11. 10.1186/1748-5908-8-1.CrossRef
23.
Eccles M, Grimshaw J, Campbell M, Ramsay C: Research designs for studies evaluating the effectiveness of change and improvement strategies. Chapter 7. Quality Improvement Research. Edited by: Grol R, Baker R, Moss F. 2004, London: BMJ Books, 97-114.
24.
Donner A, Klar N: Design and Analysis of Cluster Randomisation Trials in Health Research. 2000, London: Arnold
25.
26.
27.
28.
Nutrition and Diet Resources UK: ’Weight loss you can see’. 2011, Glasgow, UK: Nutrition and Diet Resources UK
29.
30.
31.
Jager C, Freund T, Steinhauser J, Aakhaus E, Flottorp S, Godycki-Cwirko M, Lieshout J, Krause J, Szecsenyi J, Wensing M: Tailored implementation for chronic diseases (TICD): a protocol for process evaluation in five cluster randomized controlled trials in five European countries. Trials. 2014, 15: 87-10.1186/1745-6215-15-87.CrossRefPubMedPubMedCentral
32.
Schulz KF, Altman DG, Moher D, for the CONSORT Group: CONSORT Statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010, 340: 332-10.1136/bmj.c332.CrossRef
33.
Metadata
Title
Evaluation of a tailored intervention to improve management of overweight and obesity in primary care: study protocol of a cluster randomised controlled trial
Authors
Jane Krause
Shona Agarwal
Danielle H Bodicoat
Arne Ring
David Shepherd
Stephen Rogers
Michel Wensing
Richard Baker
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Trials / Issue 1/2014
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/1745-6215-15-82

Other articles of this Issue 1/2014

Trials 1/2014 Go to the issue

Study protocol

VITamin D supplementation in renAL transplant recipients (VITALE): a prospective, multicentre, double-blind, randomized trial of vitamin D estimating the benefit and safety of vitamin D3 treatment at a dose of 100,000 UI compared with a dose of 12,000 UI in renal transplant recipients: study protocol for a double-blind, randomized, controlled trial

Study protocol

Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial

Study protocol

Forced diuresis with matched hydration in reducing acute kidney injury during transcatheter aortic valve implantation (Reduce-AKI): study protocol for a randomized sham-controlled trial

Research

Publication practices and standards: recommendations from GSK Vaccines’ author survey

Review

Ethical and scientific considerations for patient enrollment into concurrent clinical trials

Study protocol

Optimization of the viability of stem cells derived from umbilical cord blood after maternal supplementation with DHA during the second or third trimester of pregnancy: study protocol for a randomized controlled trial